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Sickle Cell Disease (SCD) is an incurable, chronic condition that results in a constellation 
of disorders, frequent emergency department (ED) visits, and repeated hospital 
admissions. Those affected often suffer from pain crisis, infection, acute chest syndrome, 
stroke, and multi-organ impairment and frequently do not receive adequate pain 
management during acute pain episodes because ED providers view them as drug 
seeking. The majority of patients with SCD are African-American and may be low 
income, uninsured, or on Medicaid. As a result, these demographics make ED under-
treatment of pain in patients with SCD a health equity issue. This was a pre-experimental 
one group pre-test/post-test quality improvement project to evaluate the effectiveness of 
implementation of an evidence-based analgesic algorithm coupled with an intervention 
on practice change behavior towards patients with SCD.  The intervention was an 
educational video and introduction of an evidence-based analgesic prescribing algorithm 
(ED-SCANS Decision 2). The outcome variables were provider perceptions (assessed by 
the Positive Provider Attitudes towards Sickle Cell Patients questionnaire) and levels of 
pain in SCD patients before and after the intervention. The results of this project 
indicated that there was a significant improvement in provider attitudes between the pre-
test and post-test scores (p<.001). There was a significant difference (p<.002) between 
discharge LOP, with the LOP approximately 3 points lower post-intervention; indicating 
that the overall results of this QI study demonstrated positive outcomes (improved 
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Background and Significance  
Sickle Cell Disease (SCD) is an incurable, long-term condition that results in 
chronic manifestations of acute painful crises (vaso-occlusive crisis or VOC), frequent 
emergency department (ED) visits, and repeat hospital admissions. Those affected often 
suffer from pain crisis, infection, acute chest syndrome, stroke, and multi-organ 
impairment and often do not receive adequate pain management during acute pain 
episodes because ED providers view them as drug seeking. Because the majority of 
patients with SCD are African-American and may be low income or uninsured or have 
Medicaid, these demographics make ED under-treatment of pain in patients with SCD a 
health equity issue.  
Problem Statement 
 Baptist Health Medical Center Little Rock Emergency Department (BHMC-LR) 
is one of the leading acute care facilities in Arkansas. From 2009-2011, the hospital 
instituted certain quality improvement initiatives, including the development and 
adaptation of treatment protocols for selected Diagnostic Related Groups (DRGs). 
However, SCD is not included in these protocols due to at least two possible reasons: 1) 
perceived physician resistance or reluctance to treat patients with SCD; or 2) a lack of 
current knowledge and awareness of the benefits of using an established protocol to 
identify and treat these patients upon their entrance into the ED setting.  
  Physicians play a vital role in coordinating care for SCD patients. Therefore, it is 
crucial these providers have a comprehensive knowledge base and a perspicacious ability 
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to think critically when treating these patients in the ED. Complications that characterize 
SCD disease presentations in the ED setting and recognition of the severity of VOC must 
be at the forefront of ED physicians’ practices when providing care for SCD patients. 
These complications include pain that physicians may perceive as drug-seeking behavior, 
frequent visits to the ED, clinician and patient knowledge deficits, and SCD stigma 
(Tanabe, 2011). Identifying appropriate treatment modalities for SCD patients who 
present to the ED with VOC can decrease hospitalizations and re-admission rates, 
inevitably decreasing costs for the hospital system because more than 1,000 patients who 
suffer from SCD live in Arkansas. While the majority of these patients have taxpayer-
funded insurance sources, the remainder has no insurance and place a major burden on 
Arkansas’s health care system to provide unreimbursed care.  
 This Quality Improvement (QI) project had the potential to benefit the hospital 
with respect to a reduction in readmission rates related to SCD. This is important for cost 
containment, which is a major area of focus for hospitals. The Centers for Medicare and 
Medicaid Services (CMS) released the Inpatient Prospective Payment System (IPPS) in 
August 2011 as a structured framework to reduce hospital readmission rates through the 
Hospital Readmission Reduction Program (HRRP), which is slated to begin in 2013 
(Lenz & Hardcastle, 2011). This program creates a system of penalties for hospitals that 
have high rates of readmission for specific diagnoses. The initial three diagnoses (heart 
attack, heart failure, and pneumonia) will be used to compare 30-day readmission rates, 
defined as “a patient being discharged to a non-acute setting and subsequently readmitted 
or admitted to another acute care hospital within thirty days of discharge” (Lenz & 
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Hardcastle, 2011, p.1) in 2012. By 2015, the diagnostic categories include chronic lung 
conditions, vascular diseases, and other diagnoses not identified to date.  
Scope of the Problem 
The conditions of SCD and VOC result in frequent hospital encounters, especially 
through the ED. There is evidence that ED providers and clinicians do not properly 
identify, treat, or manage care for SCD patients most likely due to misperceptions 
towards patients who suffer from this incurable disease (Ratanawongsa et al., 2009). 
Improper treatment of patients suffering from SCD results in re-hospitalizations with 
increased expenditures for the health care industry. This project assessed the 
effectiveness of a video intervention and the institution of an analgesic treatment protocol 
to promote change in the implementation of appropriate treatment for SCD patients 
treated at BHMC-LR ED.  
Tanabe et al. (2010) conducted one of the first prospective, multisite, longitudinal 
cohort studies, using a learning collaborative model to evaluate analgesic management in 
the ED setting. More than 75% of patients had one to three repeat visits over one year, 
which will affect CMS reimbursement under the IPPS if SCD is added as a diagnosis, as 
repeat admissions will result in unpaid hospital charges, with concomitant increases in 
expenditures. Hospitals must implement standard and appropriate treatment of SCD 
patients with VOC not only to improve patient care, but also to improve reimbursement.  
Patients who suffer from SCD often present to the ED due to VOC pain, which 
requires high dose opioids. If these patients are hesitant to seek treatment for their 
conditions, their risk of health detriment is increased. Instead, these patients require 
prompt assessment and intervention in order to interrupt this painful cycle. It is 
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imperative that providers respond appropriately to these patients, providing non-
judgmental analgesic treatment. If patients who suffer from SCD/VOC receive optimal 
pain management and treatment in the ED, then these patients may be less likely to have 
frequent repeat readmission rates. This will coincide with the HRRP by decreasing repeat 
ED visits and hospitalizations for SCD. 
Purpose  
The objective of this project was to improve current analgesia practices for SCD 
patients at (BHMC-LR ED. This QI project compared the pain control effectiveness of 
current analgesia practices for SCD patients at BHMC-LR ED with the effectiveness after 
implementation of an evidence-based analgesia support algorithm, coupled with an 
educational video shown to improve care for these patients. 
Goals and Objectives 
The goal of this project was to improve provider perceptions and actions related 
to care of patients with SCD. If provider perceptions are changed (Haywood et al., 2010), 
then practice behaviors may change, resulting in improved clinician attitudes, behaviors, 
and treatment for SCD patients who present to the ED. The providers will then use the 
analgesic treatment protocol in standard practice when treating these patients.  A key 
strategy to reach this project goal was the implementation of an evidence-based analgesic 
management algorithm, thereby improving providers’ attitudes and actions related to 
providing care and treatment to SCD patients in the ED.  
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This project’s process objectives included the following: 
• BHMC-LR ED physicians and nurses will be required to watch the intervention 
video; 
• BHMC-LR ED physicians will be encouraged to use the ED-SCANS Decision 
Algorithm to guide analgesic prescribing for SCD patient encounters; and  
• ED providers will change practice behaviors after the intervention when caring 
for patients with SCD/VOC. 
This project’s outcome objectives include the following:  
 
• Adoption of a decision support tool (i.e., ED-SCANS Decision 2) to help support 
decision-making and treatment of SCD patients in the ED; and  
• Improved analgesic care for patients with SCD/VOC. 
Policy Implications  
Based on the findings of this project, recommendations were made to BHMC-LR 
administration, the ED medical director, the ED supervisor, and the BHMC-LR 
interdisciplinary team regarding the importance of prompt triage and medical assessment 
of SCD patients who present to the ED. These patients require high dose analgesia, 
hydration, and other hemodynamic assessment parameters in order to prevent mortality, 
which can result from VOC. SCD is a global health problem and initiatives must be 
developed in order to decrease morbidity and mortality associated with this genetically 
linked, incurable disease. By providing prompt assessment and appropriate analgesia 







Lewin’s Change Management Model  
Because of shortcomings in identification, treatment, and management of patients 
who suffer from SCD at BHMC-LR ED, the student implemented this QI project. 
Lewin’s Change Management Model (LCMM) was selected as the theoretical 
framework. In this model, Lewin identified three stages of change: unfreezing, changing, 
and refreezing (as cited in Buonocore, 2004, p. 1).  
The first stage involves the identification of the occurrences that prompt the need 
for change. When all entities involved become a part of the identified need for change, 
then unified participation is possible. A motivation to enact change in current practice 
prompts the first stage (Buonocore, 2004). At BHMC-LR ED, the clinicians and social 
workers stated they were motivated to help identify measures that would improve ED 
treatment modalities for patients with SCD. Because of this motivation and a diagnosis of 
the problem in practice, then planning solutions fostered a stimulus for change in 
behavior (Buonocore, 2004).  
The need for medical treatment for patients with SCD in Arkansas is increasing. 
These patients have no cure for their condition and must endure the status quo until 
treatments improve. Hospitals in Arkansas are working to stratify options for reducing 
costs within their system, but this is hindered by repeat ED encounters by SCD in VOC. 
The costs for treatment are often placed among charges that are considered 
umreimbursable. This disrupts efforts to reduce cost escalation within the hospital 
system. Providers are then burdened with repeat patient visits in the ED with the 
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assumption that these services will not be paid upon culmination of each repeat 
encounter. The first stage (unfreezing) provides a theoretical basis on how to reduce 
obstacles to change, which will likely interrupt the above described cycle, increasing the 
potential for success of this QI project. Stakeholders are more apt to participate in the 
proposed change if the benefits are described in the initial stages of the project.   
 The second stage, change, is the alteration of current practices (i.e., attitudes, 
behaviors, inherent belief patterns in these providers, and improper analgesic 
administration) to optimize improvement in patient outcomes in the BHMC-LR ED 
(Buonocore, 2004). Theoretical knowledge channeled with experience in both 
organizational (BHMC-LR) and patient needs enabled the adaption of Lewin’s model to 
serve as a basis for “unfreezing” present behaviors and processes at BHMC-LR. This 
enabled a change to occur (the second stage of Lewin’s model), thereby leading to a 
“refreezing” (the third stage of Lewin’s model) of provider practice behavior and 
evidence-based treatment in this QI project.  Refreezing involves maintenance of the 
implemented change. This QI project was designed to permanently improve provider 
practice attitudes and treatment behaviors towards SCD patients in the BHMC-LR ED.  
Participation in this project was designed to permit the ED providers to claim a 
sense of ownership of the success of the project. Levasseur (2001) concluded that one 
key element in the unfreezing stage (to prevent project failure) is the eliciting of effective 
modes of communication at the stimulus phase in order to implement change so that all 
stakeholders are active participants involved in empowering the organizational success of 
the project’s anticipated goal.    
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 Patients and their families were also identified as stakeholders who will directly 
benefit from this project. The physicians involved identified existing biases which  
impede prompt diagnosis of patients who have SCD (with or without VOC) and foster 





 Sickle cell disease (SCD) is a complex, genetic (autosomal recessively inherited), 
multi-system illness that affects 7% of the global population, including approximately 
80,000 African-Americans (Taylor, Stotts, Humphreys, Treadwell, & Miaskowski, 2010). 
Caused by a genetic mutation resulting in glutamic acid substitution for amino acid in the 
sixth position of the mature Beta-globin chain, SCD results in polymerization and 
deoxygenation of hemoglobin. This leads to the deformation and density of red blood 
cells in patients with SCA (Brown, 2012; Mousa & Qari, 2010), causing chronic 
manifestations of acute painful crises known as VOC (Brown, 2012). This long-term 
condition results in frequent visits to the ED, with 90% of patients requiring inpatient 
admission because of painful episodes of the sickle cell crisis (Brown, 2012). Due to the 
pathophysiology (vaso-occlusion) of sickle cell anemia (SCA), these patients have 
increased morbidity and mortality attributed to acute and chronic complications. These 
include pain crisis, infection, acute chest syndrome, stroke, and multi-organ (brain, heart, 
lungs, liver, bone, skin, kidneys) hemolysis (Mousa & Qari, 2010).  
Patients who suffer from SCA and SCD present frequently to the ED because of 
VOC, appearing very ill and presenting extreme subjective complaints of pain, often 
requiring high doses of opioids. ED medical providers are faced with repeat patient 
encounters, often related to uncontrolled pain. However, it may be difficult for providers 
to distinguish objectively patients who have SCD with VOC-generated pain from 
individuals who present with other subjective and undetermined causes of pain or who 
are drug seeking because of addiction.  
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Approximately 980,000 individuals are addicted to opiates nationally (CNN 
Health, 2010). CNN Health (2010) reports that between 2004 and 2009, there had been a 
111% surge in ED visits entailing therapeutic misuse of prescription opiate analgesics, 
with correlated data that validates prescription medication abuse as the most accelerating 
drug problem in the country. These statistics are a compelling concern for ED physicians 
and frequently create the potential to discount analgesia requests by patients in the ED.  
However, patients who live with SCD must be managed on a long-term basis for 
acute episodes of pain (Epstein, Yuen, Riggio, Ballas, & Moleski, 2006), as well as be 
given general health maintenance and follow-up care. Therefore, these patients typically 
interface with the health system for episodic pain not controlled via oral analgesia, 
resulting in frequent utilization of the ED for treatment. 90% of all patients who present 
to the ED in VOC are admitted for inpatient treatment (Epstein et al., 2006).  
In addition, re-hospitalization is frequent among patients with SCD with one-in-
five patients having greater than three encounters annually (Brousseau, 2010) and one-in-
three re-hospitalized within 30 days. This was greater in comparison to other diseases 
(heart failure, diabetes mellitus, asthma, and pneumonia) frequently seen in the ED 
(Brousseau, 2010), resulting in increased health expenditures. However, it is very likely 
that if proper acute care management of SCD patients is instituted with outpatient follow-
up visits (Brousseau, 2010), then re-encounters can be decreased.  
 The Sickle Cell Disease Association of America, Inc. (SCDAA) estimates that in 
the United States more than 100,000 individuals have the disease. In addition, numerous 
other organizations also address treatment issues surrounding SCD, including the 
NAACP, Urban League, National Institutes of Health (NIH), Health Resources and 
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Services Administration, Centers for Disease Control and Prevention (CDC), United 
Way, and the Robert Wood Johnson Foundation, by employing efforts at knowledge 
advancement and treatment (Sickle Cell Disease Association of America, 2012).  
 President Richard Nixon signed into law the Sickle Cell Anemia Control Act in 
1971, which contained provisions to decrease prior neglect of persons with SCD by 
allotting monies for screening, education, and research towards SCD. Furthermore, 
President George W. Bush signed the Sickle Cell Treatment Act in 2003, which contains 
major initiatives to enhance care quality globally for patients suffering from SCD 
(SCDAA, 2012). As a result, diagnosticians are in primary positions to engage in practice 
change initiatives and service improvement for SCD patients.   
 However, improving access to proper treatment requires that clinicians be 
knowledgeable and receptive to the needs of these patients. Perceptual biases may 
pervade treatment modalities when these patients seek help during painful crises. 
Therefore, this project focused on the education of ED providers by allowing them to 
view SCD patients as individuals in need of help for an incurable disease that health care 
providers often stigmatize.  
 Provider attitudes can have a negative impact on the general receptiveness to 
providing optimal care to SCD patients. A study by Lattimer et al. (2010) found that SCD 
patients often report problems with receiving treatment, especially pain relief from ED 
providers. These patients also stated that they are undertreated and accused of behaviors 
that mimic those of drug-seekers, with clinicians displaying negative and judgmental 
attitudes towards their pain. Providers (physicians and nurses) often assume that SCD 
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patients develop addictions to opioids, although current literature supports the claim that 
there are only rare instances of addiction among these patients (Lattimer et al., 2010).  
SCD patients who encounter negative experiences in the health care industry have 
increased risk for morbidity associated with their disease, resulting from their hesitation 
to seek care and treatment and from the resulting improper treatment for their disease. 
For example, Lattimer et al. (2010) measured the hospital encounters of 45 patients via a 
standard research tool (The Picker Patient Experience Questionnaire, PPE-15) in a cohort 
study. Results indicated that 86% of these patients were not involved in their care 
decisions, and 64% received unclear information, including vague answers to treatment 
questions (Lattimer et al., 2010). Likewise, in a cross-sectional study of 95 patients by 
Haywood et al. (2010), adult SCD patients made continual subjective reports of negative 
experiences when seeking care in health facilities. Clinicians discounted their reported 
pain as drug-seeking behavior, leading to a mutual distrust between providers and these 
patients. Poor or biased modes of provider communication were associated with negative 
patient experiences and lower levels of trust toward providers when seeking treatment for 
SCD/VOC in the health setting.  
 Despite provider attitude biases towards SCD patients, global initiatives for 
improving quality of care for these patients may be possible. Knowledge and awareness 
are fundamental components of interventions that will improve care and treatment for 
these patients. Once this gap has been bridged, providers and healthcare organizations 
(hospital EDs, urgent care centers, etc.) may be more apt to institute a tool that supports 
treatment for SCD patients.  
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A qualitative study by Tanabe et al. (2010) identified an adult treatment tool 
(Emergency Department Sickle Cell Assessment of Needs and Strengths or ED-SCANS) 
as effective in assisting ED providers to treat patients who have SCD/VOC. This study 
assessed variations in clinician perceptions of potential drug-seeking behavior among 
patients both in and out of the ED setting, compared to those diagnosed with SCD. 
Participants came from seven different states, including Kansas, Tennessee, and 
Louisiana, which are neighboring states to Arkansas. A major finding was the rate of 
frustration among ED clinicians over numerous ED visits, hospitalizations, and 
difficulties maintaining adequate follow-up (outpatient care) and analgesic administration 
for these patients. 
 Pham (2008) found that EDs are the main portals of entry into the health care 
system despite their reputation for misdiagnosis, negligence, and medical errors. 
Specifically, in 2003 there were more than 1 million ED visits by patients in the United 
States (a frequency of two visits per five people). This setting (providing access to care 
24 hr daily, 7 days per week) often provides care for persons with minimal or no 
insurance, including some patients with SCD who lack optimal outpatient management. 
To optimize care, SCD patients must feel that providers are receptive to their 
physiological and emotional needs, which will permit a prompt initiation of care 
measures (triage, assessment, analgesia, hydration, and discharge planning).  
Ratanawongsa et al. (2009) conducted a landmark cohort study that measured the 
reliability and validity of an assessment scale that focused on provider attitudes towards 
patients with SCD in VOC. This scale (Positive Provider Attitudes toward Sickle Cell, or 
PASS, Appendix A), consisting of 10 items, was given to providers within 72 hr of 
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patient treatment. The developers of the PASS questionnaire measured validity and 
reliability of the questionnaire using bivariate correlations (p<0.001) with the Medical 
Condition Regard Scale (Haywood et al., 2010a). 
 Furthermore, a study by Haywood et al. (2010b) used a video intervention method 
to determine whether provider (N = 276) attitudes towards SCD patients would be 
affected. Providers completed the PASS questionnaire before and after watching a video 
in which actual patients discussed their negative ED encounters. These encounters 
included biased actions by providers in the ED setting that occurred amidst the 
tormenting pain caused by VOC. There was a significant difference between pre- and 
post-video attitudes towards SCD in a total of three out of four outcome measurement 
items, including a profound difference noted in the reduction of negative provider 
attitudes towards these patients after viewing the video.   
 In addition, Odesina (2010) identified pain crises as the main reason that most 
patients who suffer from SCD seek treatment in the ED. Her findings validated the 
assumption that stigmatization among providers’ leads to deficiencies in prescribed 
analgesia for these patients. Odesina (2009) identified the etiology of chronic pain among 
SCD patients as follows: organ damage, iron toxicity, neurological damage, and kidney 
and liver impairment. These recurrent pain episodes cause deficits in SCD patients’ 
quality of life (QL). She stated the following:                                          
 The combination of constant unpredictable pain, inadequate pain management by 
 clinicians, and emotional distress is a cycle of despair, which can lead to anxiety  
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and depression coupled with the sense of losing control; clinicians must recognize 
that improving health outcomes will play a significant role in improving health 
related QL (p.8). 
Lastly, the Arkansas Legislative Task Force on Sickle Cell Disease (ALTFSCD) 
Report to the Arkansas General Assembly (August, 2010) stated the following:  
• SCD affects more than 1,000 Arkansans; 
• poor channels of access for SCD patients increase patient entry into the 
hospital setting, especially the ED; 
• great portions of SCD patients are unemployed or work jobs at minimum 
wage pay; 
• many Arkansas hospitals are left with unreimbursed charges because of 
frequent and repeat ED visits and hospitalizations; 
• there are numerous advantages to the state, the patient, the hospital, and 
the community to having improved health outcomes for SCD patients 
(Johnson et al., 2010). 
 To help alleviate the challenges cited, the ALTFSCD outlined eight key 
recommendations, which included the development of a Comprehensive Sickle Cell 
Program using large centers and peripheral sites in the state of Arkansas. A key 
component of this initiative includes the targeting of physicians as a means to educate 
and generate change in prior and current practice methodologies in order to institute 
change in future practice for patients with SCD.   
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The ALTFSCD also states the following:  
• many physicians may not actually know the proper treatment for patients 
with SCD due to its low prevalence; 
• pain management is most challenging to physicians because patients 
require large doses of opioid analgesia. The recommended protocol is to 
deliver a bolus (large dose) of medication to get ahead of the pain curve; 
• providers often misinterpret continued requests for pain medication as 
drug-seeking behavior; hence physicians develop perceived biases towards 
these patients, thereby demonstrating resistance to prescribing appropriate 
doses of medication; 
• patients often feel disrespected by their physicians, developing distrust for 
the health care system in general; 
• the care of sickle cell patients is fragmented for adult patients because 
there is no comprehensive adult “medical home” for ongoing treatment 
and management of SCD; 
• medical providers demonstrate a reluctance to provide local acute care to 
these adult patients. 
With treatment improvements, morbidity and mortality in the SCD population 
would decrease while also resulting in increased cost savings for the health care industry 
in Arkansas (Brousseau, 2010). This QI initiative incorporated nursing science and 
evidence-based measures to improve provider perceptions and analgesic practices, 
thereby enacting change within BHMC-LR. Organizational change must be grounded on 





Design, Setting, Sample 
 This was a pre-experimental one group pre-test/post-test quality improvement 
project to evaluate the effectiveness of implementation of an evidence-based analgesic 
algorithm coupled with an intervention on practice change behavior towards patients with 
SCD.  The intervention was delivered in a private conference room at BHMC-LR ED.  
The ED supervisor and medical director scheduled the intervention times and days. The 
video was shown on a laptop computer, using an attached speaker for sound clarity. The 
analgesic algorithm and the pre-and-post PASS questionnaires were provided in paper 
format to all participants.   
The participants consisted of ED nurses and physicians employed by (or of 
medical staff designation within) BHMC-LR ED for at least 12 months. Exclusion 
criteria included employment for fewer than 12 months. There were no racial, ethnic, or 
gender exclusions made among the participants. There were no special accommodations 
(related to speech, visual, hearing, or physical limitations) required or requested.   
Procedure 
After receiving approval and proposal acceptance from the University of Nevada 
Las Vegas (UNLV) Doctor of Nursing Practice project committee, the BHMC-LR 
Corporate Compliance department (with submission of a project approval letter), and the 
UNLV Institutional Review Board (IRB), this QI project proceeded.. The DNP student 
met with the BHMC-LR ED supervisor and medical director to ascertain that all aspects 
of the intervention were reviewed in detail and acceptable to all members of the 
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interdisciplinary team. The ED supervisor scheduled the intervention during participants’ 
regular work schedule over two weeks in December 2012. Participation in the research 
component was voluntary (although the ED supervisor arranged scheduling for all 
providers for the intervention).  
Intervention 
 This intervention involved the completion of a pretest questionnaire (for those 
who consented to participate in the research portion), viewing an 8-miinute video 
(depicting actual patients with SCD and a hematologist describing the impact of SCD and 
the obstacles encountered when looking for medical treatment during pain crises), and 
presentation of an evidence based analgesic algorithm. The student provided the 
participants with the following: purpose for participation (via verbal briefing format), 
instructions for participation in the intervention, and privacy and confidentiality 
information.  
Each participant received a pen and a folder that contained the following:  
• UNLV IRB project approval letter 
• BHMC-LR Corporate Compliance project approval letter 
• informed consent forms 
• unique identifier form (to match pre- and post- questionnaires)  
• procedure instructions 
• color coded questionnaires (yellow=pre, blue=post), and  
• color copies of the ED-SCANS Decision 2 Analgesic Algorithm.  
After each participant completed the informed consent and unique identifiers, 
they completed the pre-questionnaire, watched the 8-minute video, and then completed 
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the post-questionnaire. After that, the student reviewed the ED-SCANS Decision 2 
Analgesic algorithm and discussed it with each participant.     
Variables 
 The dependent variables in this study were provider perceptions using a 
qualitative Likert scale (pre- and post-intervention) and provider practices of analgesia 
prescribing (pre and post intervention) using data obtained from the PCQI report. The 
independent variables were watching the 8-minute video and presentation of the 
analgesic algorithm (ED-SCANS Decision 2).  
Data Collection 
 Participants completed a questionnaire (PASS) that collected provider perceptual 
responses regarding prior interactions with SCD patients, beliefs/opinions about SCD 
patients’ pain and potential for manipulation of providers, and overall perceptions 
towards SCD patients in general. There were no monetary incentives offered for 
participation.   
The 10 item PASS questionnaire was developed by Ratanawongsa et al. (2009). It 
includes the following items.  
Questions 1-3 with Likert scale responses of 1 (much less than average) to 5 (much 
more than average): 
1. How much do you like this patient (liking means warmth/enthusiasm for seeing)? 
2. How much empathy do you have for this patient? 
3. How much respect do you have for this patient? 




4. This patient was frustrating to take care of; 
5. This patient is one of those people who makes me feel glad I went into medicine; 
and 
6. This patient is the kind of person I could see myself being friends with. 
Questions 7-10 with Likert scale responses of 1 (not at all likely) to 5 (extremely 
likely): 
7. In your opinion, how likely is this patient to over-report (exaggerate) discomfort? 
8. In your opinion, how likely is this patient to fail to comply with medical advice? 
9. In your opinion, how likely is this patient to abuse drugs, including alcohol? In 
your opinion, how likely is this patient to abuse drugs, including alcohol? 
10. In your opinion, how likely is this patient to try to manipulate you or other 
physicians? 
The ED-SCANS Decision 2 Analgesic Algorithm provides dosage recommendations 
(per weight in kilograms) using either intravenous or subcutaneous routes of 
administration for morphine or hydromorphone in treating SC crisis pain in the ED. The 
student gave participants an overview of the algorithm and provided an opportunity to 
discuss their thoughts on the intervention and algorithm.  
Data Analysis 
 The participants’ responses and data obtained from the PCQI report were entered 
into SPSS Version 19. All user-defined missing values were indicated as missing. 
Statistics for each test were based on all cases with valid data for each variable per test.  
Paired t-tests were used for data analysis of pre- and post-test PASS scores, and an 
independent samples t-test was used for pre-and post-intervention PCQI pain scores.  
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The International Classification of Disease (ICD) DRG was used to identify SCD 
patient encounters from the PCQI report. A data abstraction tool was used to collect the 
data from the PCQI report (25 SCD patient encounters) obtained for the period of 30 days 
prior to and 30 days after the intervention. Data were entered into SPSS per subject using 
the following variables: triage level of pain (LOP); LOP 1 hour post analgesia 
administration; and discharge (from ED) LOP. All user defined missing values were 
treated as missing in the data analysis. 
 The pre- and post-intervention provider response scores were calculated as 
follows: the range of scores for the pre and post PASS questionnaires was 1-10 (with 10 
being the higher and most positive attitude). The individual pre- scores (for each 
questionnaire) were matched with the post- scores using the unique identifiers. A total 
score was calculated for each questionnaire; individual questions were not analyzed, in 






Fifty participants completed the pre- and post-questionnaire (Table 1). Using a 
paired samples t-test, there was a significant difference at the p<.001 level between the 
scores. 
Table 1 
PASS Questionnaire Results 
 M N SD SEM 
Pre-Intervention 22.20 50 7.809 1.104 
Post-Intervention 42.96* 50 5.047 .714 
*Significant difference (p<.001) 
PCQI 
There were some missing data points. In the pre-intervention time period, four 
patients had no triage level of pain (LOP) documented. Eight of the patients had no 1 hr 
LOP reassessment after receiving analgesia. Seven of the patients had no discharge LOP 
documented. In the post-intervention period, four of the patients had no triage LOP 
documented. Five patients had no 1 hr LOP documented after anesthesia, and six patients 
had no discharge LOP documented.  
Using independent samples t-tests, there was no significant difference in Triage 
LOP between the pre- and post-intervention samples, indicating the patients’ pain levels 
were approximately the same upon admission.  However, there was a significant 
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difference (p<.002) between Discharge LOP, with the LOP approximately 3 points lower 
post-intervention (Table 1). 
Table 2  
PCQI Results 
Pain Measurement 
Time Pre or Post Group N M SD SEM 
Triage LOP Pre Intervention 21 7.14 3.425 .747 
Post Intervention 21 8.43 2.357 .514 
LOP 1 Hour Post 
Analgesia 
Pre Intervention 17 7.00 1.732 .420 
Post Intervention 20 6.10 3.007 .672 
Discharge LOP* Pre Intervention 18 6.67 2.828 .667 
Post Intervention 19 3.74 2.535 .582 
* Significant difference p<.002 
 
Resources and Costs 
This project was implemented at no cost to BHMC-LR. The project did not 
require any staff overtime or scheduling changes. The student provided all materials 




 The student completed the project proposal defense on July 12, 2012. The initial 
proposal defense was on April 26, 2012 but a committee change necessitated a repeat 
proposal defense. Permission to proceed with the project was given by BHMC-LR on 
August 17, 2012. The student requested a “Letter of Authorization to Conduct Research” 
(LACR) from BHMC-LR on August 30, 2013.  BHMC-LR did not provide the LACR, a 
mandatory requirement by the UNLV IRB, for several months due to bureaucratic 
requirements. This delayed the project. On November 12, 2012, BHMC-LR submitted 
LACR to the UNLV Office of Research Integrity, which approved the protocol on 
November 17, 2012.  
The student then began to discuss (with BHMC-LR ED nursing supervisor) dates 
for project implementation. There was a delay in scheduling due to the hospital’s 
undergoing a transition to electronic medical records September 2012 through December 
2012. As a result, the student was not permitted to begin project implementation until 
December 2012. Correspondence with the ED Nursing Director, the ED Medical 
Director, the ED Nursing Supervisor, and the student determined a beginning 
implementation date of December 13, 2012. The PCQI report was reviewed with the ED 
supervisor for the 30 days prior to the project intervention. The project was completed on 
December 27, 2012. The student and the ED supervisor reviewed the PCQI report one 
month after the project was completed, which included all SCD patient encounters during 
the 30 days following the intervention. Data analysis was completed January 2013. A 
summary of the findings and further recommendations based upon the findings of the 
study were made to BHMC-LR stakeholders and the interdisciplinary committee 
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February 2013. The final presentation of the DNP Doctoral Project defense was 
completed on March 13, 2013.   See Appendix E for detailed project timeline. 
Ethical Consideration and Human Subjects Protection 
The student completed the required CITI course prior to implementation of this 
study and maintained compliance with all required ethical principles, protecting the 
safety, welfare, and rights of all subjects and participants involved in conducting this 
study.  Approval was received from the UNLV IRB and BHMC-LR Corporate 
Compliance department prior to project implementation. Written consent (containing 
research purpose, duration, number of subjects, procedures, exclusions, risks, benefits, 
alternatives, new information, confidentiality, and costs, the right to withdraw or refuse, 
and contact information) was obtained from all participants. See Appendix F    
This project did not require a patient privacy disclosure or direct patient 
participation because the PCQI report contained only aggregate data. To maintain privacy 
and confidentiality, participants were not required to disclose any personal identifying 
information and a unique identifier system was used to compare pre and post 
questionnaire results of each participant. Data obtained were used to determine the 











 This QI project demonstrated positive outcomes from the applied intervention. 
The findings of this QI study indicated statistically significant support of the following  
outcomes including the following: 
• BHMC-LR ED physicians and nurses demonstrated improved perceptions 
towards SCD patients after completing the video intervention; and 
• BHMC-LR ED physicians and nursing clinicians’ post-video practice behavior  
demonstrated improvement in providing appropriate SCD treatment to patients as 
evidence by a significant improvement in discharge level of pain. 
There were some unanticipated findings upon completion of the intervention, which 
indicate the need for additional practice change behavior among the nursing clinicians at 
BHMC-LR ED. Pain assessment (at triage, one hour after analgesia, and upon discharge) 
is imperative for SCD patients. Upon review of the PCQI report (pre-and-post 
intervention) it was determined that the nurses were not completing appropriate 
assessment of patients LOP at triage, one hour after analgesia, or at discharge. Care could 
improve if appropriate nursing assessment of pain is completed as required by The Joint 
Commission. In order for providers to institute permanent change in analgesia 
prescribing, they must have concise documentation of patients subjective LOP.  
Limitations 
This QI study had several limitations. The intervention was brief and one time only. 
There was no chart review to assess whether prescribing practices had improved or 
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whether the changes were sustained over time. The findings did indicate a decrease in 
negative provider perceptions towards SCD patients, but there was no repeat testing later 
to determine whether or not their perceptions remained improved.  
Strengths 
 This QI project demonstrated that it is possible to change providers’ negative 
attitudes towards patients with SCD and to improve their pain management. The 
intervention was of low cost; allowing other organizations to replicate this practice 
improvement initiative with little disruption to ED provider schedules. 
Recommendations 
 Recommendations to BHMC-LR ED include the following, based upon the 
completion of this QI study: 
• quarterly clinical staff educational sessions regarding the importance of 
documenting LOP on all patients upon triage, one hour after analgesic 
administration, and upon discharge; 
• subjective and objective pain assessment on all patients upon entrance into the 
ED, one hour after administration of analgesia, and upon discharge; 
• ED Supervisor to perform monthly PCQI assessment of analgesic practices 
among SCD patients who are treated in the ED; 
• monthly clinician (physicians and nurses) meetings to discuss PCQI data and 
intervention strategies for improvement in the delivery of health services to SCD 
patients; 
• administration monitoring of frequency (increases and decreases) among SCD 
patients following this QI project; 
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• ED Supervisor to attend quarterly meetings held by the Arkansas Minority Health 
Commission to increase educational awareness about the needs of this patient 
population and works currently underway for this population in Arkansas; 
• community alliance between BHMC-LR and the University of Arkansas for 
Medical Sciences upcoming Adult Sickle Cell Day Clinic (ASCDC); allowing for 
SCD to receive discharge instructions that include follow-up with community 
providers and the ASCDC; 
• ED Supervisor to perform quarterly educational opportunities for clinical staff 
specific to SCD assessment, treatment, and follow-up; and 













FISCAL IMPLICATIONS FOR CHANGE 
 The outcome of this project may result in decreased ED visits, revisits, and 
hospitalizations at BHMC-LR. The result is likely to be cost containment by reduction of 






















SUSTAINING AND MAINTAINING THE CHANGE 
 Upon completion of this project (intervention, data collection, and data analysis), 
the student met with the BHMC-LR interdisciplinary team reviewing the results and 
recommendations for practice using the third stage of Lewin’s Change Management 
Model. The student reviewed the pre-intervention and post intervention PCQI data in 
detail with the team, as well as the results of the pre- and post-intervention provider 
responses, based on the video and analgesic algorithm intervention. The ED-SCANS 
analgesic algorithm was reviewed with the team and suggested for adoption into practice 
in the ED. The benefits of decreased SCD admissions, decreased SCD ED visits, and 





QUALITY IMPROVEMENT AND DOCTORAL ADVANCED NURSING PRACTICE 
This QI project is representative of the standards set forth by the 2006 American 
Association of Colleges of Nursing (AACN) Essentials for Doctoral Advanced Nursing 
Practice.  The following description provides support for this project: 
• Essential I: Outlines that Doctor of Nursing Practice (DNP) graduates possess a 
wide array of knowledge from the sciences and have the ability to translate that 
knowledge quickly and effectively to benefit patient in the demands of practice 
environments; 
• Essential II: States that DNP graduates should be prepared with sophisticated 
expertise in assessing organization, identifying systems’ issues, and facilitating 
organization-wide changes in practice delivery. In addition, Advanced Nursing 
Practice requires political skills, systems thinking, and the business and financial 
acumen needed for the analysis of practice quality and costs; 
• Essential III: States that the scholar applies knowledge to solve a problem via the 
scholarship of application (referred to as the scholarship of practice in nursing). 
This application involves the translation of research in to practice and the 
dissemination and integration of new knowledge, which are key activities of DNP 
graduates. The scholarship of application expands the realm of knowledge beyond 
mere discovery and directs it toward humane ends. Nursing practice epitomizes 
the scholarship of application through its position where the sciences, human 
caring, and human needs meet and new understanding emerge; 
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• The goal of Evidence-Based practice as per the student’s anticipated role as a 
DNP is that of promoting effective nursing interventions, efficient care, and 
improved outcomes for patients and to provide the best available evidence for 
clinical, administrative, and educational decision making. DNP graduates have a 
significant role in advancing the production of nursing knowledge. It is essential 
to link the synergy for knowledge with the practice and dissemination of 
knowledge and theoretical thinking. This QI project is a clear demonstration of 
the integration of the essentials set forth by the AACN and the student’s ability to 





IMPLICATIONS FOR PRACTICE AND CONCLUSION 
SCD is an incurable chronic disease, and the delivery of health services to SCD 
patients must integrate measures for the bridging of current gaps in legislation and 
clinical treatment. QI initiatives must be predicated on evidence-based measures by 
which care for these patients can be optimized. It is essential that providers have a 
formidable knowledge base regarding the treatment of SCD and VOC, including the 
imperative nature of prompt recognition and treatment in the ED setting.  
According to Smith, Oyeku, Homer, and Zuckerman (2006), there is a nationwide 
focus on QI for the delivery of medical care. However, there has been minimal actual 
progression in the channels of care for SCD or in the development of new models 
(including refinement of older models of care) of QI for SCD, which continue to impede 
the delivery of health services for SCD treatment. DNP clinicians have the knowledge 
and clinical expertise to develop interventions for QI among SCD patients, including 
reformation of current models of care delivery. DNPs are essential agents of 
dissemination for improved methods of access, improved cost-efficacy, reduction of 
provider frustration via the promotion of community resources for outpatient 
management of SCD, and in improving outcomes in treatment for patients who suffer 
from SCD. 
Conclusion 
This project improved outcomes for SCD patients and will likely reduce ED and 
hospital readmission rates at BHMC-LR.  The administrators, ED Medical Director, ED 
Nursing Director, and ED Nursing Supervisor are considering the adoption of a decision 
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support tool (i.e., ED-SCANS) to help support future decision-making and treatment of 
SCD patients in the ED.  
The Doctor of Nursing Practice (DNP) team leader mobilized BHMC-LR 
stakeholders to unite in achieving the common goal of improving outcomes, increasing 
containment, and improving life quality and health outcomes for SCD patients at BHMC-
LR. Levasseur (2001) found that if a crisis motivates a change, and if this change is 
motivated by a need to improve a given system’s productivity, then actual change is 
possible. Using this model demonstrated improvement in the perceptions and attitudes of 
BHMC-LR ED providers and provoked measures for sustaining this level of treatment at 
this ED. By problem identification, solution development, change implementation, and 
the re-establishment of balance in practice behavior (Buonocore, 2004), BHMC-LR 
demonstrated an evidence-based change in practice behaviors, optimizing and enhancing 






APPENDIX A:  PASS QUESTIONNAIRE 
Positive Provider Attitudes toward Sickle Cell Patients Scale (PASS) Score 
Source: Ratanawongsa N, Haywood C, Bediako SM, Lattimer L, Lanzkron S, Hill PM,  Neil R. Powe NR, 
Beach MC. “Health care provider attitudes towards patients with acute vaso-occlusive crisis due to sickle 
cell disease: development of a scale.” Patient Education and Counseling 2009. 76(2):272-8. 
 
Not every patient is regarded the same. 










1. How much do you like this patient? (Liking 
























3. How much respect do you have for this 
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4. This patient was frustrating to take care of. 
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5. This patient is one of those people who make me 












6. This patient is the kind of person I could see 
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 7. …over-report (exaggerate) discomfort?  
 
1 2 3 4 5 
 8. …fail to comply with medical advice?  
 
1 2 3 4 5 
9. …abuse drugs, including alcohol?  
 
1 2 3 4 5 
10.…. try to manipulate you or other physicians? 
 
 
Additional item (not part of PASS score): 
 
1 2 3 4 5 
Compared to other patients with pain crises, how 






















• Total possible score: 10 – 50 (higher scores indicate more positive attitudes) 
• Items 5-10 are reverse-scored. 
• Cronbach’s alpha in study = 0.913 
• Item sources: 
• Newly-created items: questions 3, 5, and 7 
• Question 1: Hall JA, Horgan TG, Stein TS, Roter DL. Liking in the physician--patient relationship. Patient Educ 
Couns 2002; 48(1):69-77. 
• Question 3: Beach MC, Roter DL, Cooper LA. Are physicians’ attitudes of respect accurately perceived by patients 
and associated with more positive communication behaviors? Patient Educ Couns 2006; 51: 347-54. 
• Questions 7-10: van Ryn M, Burke J. The effect of patient race and socioeconomic status on physicians’ perceptions 





APPENDIX B: CRISIS VIDEO LINK 
“CRISIS: Experiences of People with Sickle Cell Disease Seeking Healthcare for Pain” 
 



















                                                                                                                                                                                                 




APPENDIX D: DETAILED PROJECT TIMELINE 
Project Task Dates 
• Initial Project Proposal Defense to Project Committee April 26, 2012 
• Project Committee Member Change Completed  May 7, 2012 
• Completion of Recommended Changes to Project Proposal June 26, 2012 
• Proposal turned in to Project Chair June 29, 2012 
• Proposal Defense to Project Committee July 12, 2012 
• Authorization to Proceed with Project Received from BHMC-LR 
Corporate Compliance Department 
August 17, 2012 
• Initial Letter of Authorization to Conduct Research received from BHMC-
LR 
August 27, 2012 
• Meeting held between Project Chair, BHMC-LR QI Director, and student November 12, 2012 
• Revised and completed Letter of Authorization to Conduct Research 
received from BHMC-LR Corporate Compliance Department 
November 12, 2012 
• UNLV IRB protocol approval received/Expedited Review November 17, 2012 
• Student and BHMC-LR ED Supervisor planning for project 
implementation dates 
November 18, 2012 
• Project implementation began at BHMC-LR ED 
• Review of PCQI Report (30 days prior to period before intervention)  
December 13, 2012 
• Conclusion of project implementation at BHMC-LR ED December 27, 2012 
• Review of PCQI Report (30 day time period following intervention) January 23, 2013 
• Data Analysis with Project Chair January/February 
2013 
• Summary and presentation of findings to BHMC-LR stakeholders February 2013 
• Completion of Writing of Final Project February 2013 
















INFORMED CONSENT  
Department of Nursing 
    
TITLE OF STUDY:                                                                                                                                   
Sickle Cell Disease: A Quality Improvement Initiative for Emergency Department Providers 
INVESTIGATOR(S): Nancy Menzel, PhD, RN; Pretrescia Walker, MNSc. APN, ACNP  
For questions or concerns about the study, you may contact Pretrescia Walker at (501)-766-3648 
or Nancy Menzel at (702) 895-5970.   
 
For questions regarding the rights of research subjects, any complaints or comments regarding 
the manner in which the study is being conducted, contact the UNLV Office of Research 
Integrity – Human Subjects at 702-895-2794, toll free at 877-895-2794 or via email at 
IRB@unlv.edu. 
    
 
Purpose of the Study 
You are invited to participate in a research study.  The purpose of this study is to improve current 




You are being asked to participate in the study because you fit this criteria: You are either a 
nurse or physician, employed (for greater than 12 months) by or with staff designation at Baptist 
Health Medical Center-Little Rock, Arkansas. 
 
Procedures  
If you volunteer to participate in this study, you will be asked to do the following: You will be 
asked to complete the pre-training questionnaire “Positive Provider Attitudes Towards Sickle 
Cell Patients Scale” (PASS), then watch the 7-minute video “Crisis: Experienced of People With 
Sickle Cell Disease Seeking Healthcare for Pain,” then complete the post-training PASS 
questionnaire, then attend a 10-minute presentation on an analgesic support algorithm entitled 




Benefits of Participation  
You may benefit from participating in this study by having an increased awareness of the 
analgesic needs of patients who present to the Emergency Department for treatment. 
 
Risks of Participation  
There are risks involved in all research studies. This study may include only minimal risks.  You 
may become uncomfortable when watching the video or in answering some of the questions on 
the questionnaire.   
 
Cost /Compensation  
There are no financial costs to you to participate in this study.  The study will take 30 minutes of 
your time during your scheduled shift.  There will be no compensation for your time.    
 
Confidentiality  
All information gathered in this study will be kept as confidential as possible.  No reference will 
be made in written or oral materials that could link you to this study.  All records will be stored 
in a locked facility at UNLV for 3 years after completion of the study.  After the storage time, 
the information gathered will be shredded.  
 
Voluntary Participation  
Your participation in this study is voluntary. You may refuse to participate in this study or in any 
part of this study.  You may withdraw at any time without prejudice to your relations with 
UNLV or Baptist Health Medical Center. You are encouraged to ask questions about this study 
at the beginning or any time during the research study.  
 
Participant Consent:  
I have read the above information and agree to participate in this study.  I have been able to ask 
questions about the research study.  I am at least 18 years of age.  A copy of this form has been 




             
Signature of Participant                                             Date  
 
        















Biomedical IRB – Expedited Review 
Approval Notice 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a modification for any change) of an IRB approved 
protocol may result in mandatory remedial education, additional audits, re-consenting subjects, researcher 
probation, suspension of any research protocol at issue, suspension of additional existing research protocols, 
invalidation of all research conducted under the research protocol at issue, and further appropriate consequences 
as determined by the IRB and the Institutional Officer.  
 
DATE:  November 14, 2012  
TO:   Dr. Nancy Menzel, Nursing  
FROM:  Office of Research Integrity - Human Subjects  
RE:                      Notification of IRB Action                   
  Protocol Title: Sickle Cell Disease: A Quality Improvement Initiative for Emergency  
  Department Providers         
  Protocol #: 1209-4242          
  Expiration Date:  November 13, 2013  
____________________________________________________________________________________ 
This memorandum is notification that the project referenced above has been reviewed and approved by the UNLV Biomedical 
Institutional Review Board (IRB) as indicated in Federal regulatory statutes 45 CFR 46 and UNLV Human Research Policies and 
Procedures.  
 
The protocol is approved for a period of one year and expires November 13, 2013. If the above-referenced project has not been 
completed by this date you must request renewal by submitting a Continuing Review Request form 30 days before the expiration 
date.  
 
PLEASE NOTE:  
Upon approval, the research team is responsible for conducting the research as stated in the protocol most recently reviewed and 
approved by the IRB, which shall include using the most recently submitted Informed Consent/Assent forms and recruitment 
materials. The official versions of these forms are indicated by footer which contains approval and expiration dates.  
Should there be any change to the protocol, it will be necessary to submit a Modification Form through ORI - Human Subjects. 
No changes may be made to the existing protocol until modifications have been approved by the IRB. Modified versions of 
protocol materials must be used upon review and approval. Unanticipated problems, deviations to protocols, and adverse events 
must be reported to the ORI – HS within 10 days of occurrence.  
 
If you have questions or require any assistance, please contact the Office of Research Integrity - Human Subjects at 
IRB@unlv.edu  or call 895-2794. 
 
Office of Research Integrity - Human Subjects 4505 Maryland Parkway • Box 451047 • Las Vegas, Nevada 89154-1047                    
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OBJECTIVE To maintain full-time employment with an Acute Care Facility  as an 
Acute Care Nurse Practitioner or in a university or academic institution as 
a College of Nursing faculty member. 
    
 
EDUCATION  *University of Nevada Las Vegas-Doctor of Nursing Practice Program 
*Board Certified Acute Care Nurse Practitioner 
   *Licensed Advanced Practice Registered Nurse 
*University of Arkansas for Medical Sciences- MNSc 
   *University of Central Arkansas (UCA) - BSN 
   *Critical Care Certification                                                                                                                                        






2009-present Administrator/Clinical Leader/Educator for Walker Internal Medicine 
Clinic, P.A. in Little Rock, Arkansas 
 
2009-2011 Team Leader /Rapid Response Team Member for The Rapid Response 
Team at The Department of Veterans Affairs Medical Center in Little 
Rock, Arkansas. 
 
2001-2009 Acute Care Nurse Practitioner for Walker Internal Medicine Clinic, P.A. 
in Little Rock, Arkansas 
    
2004-2005 50% Faculty Appointment with the University of Arkansas for Medical 
Sciences as a Clinical Instructor 
 
2001-2004 Part-Time Clinical Instructor at the University of Arkansas for Medical 
Sciences-College of Nursing  
  
1999-2001 Acute Care Nurse Practitioner clinical practicum in Internal Medicine, 
Cardiology, Pulmonology, and Nephrology 
 
1995-2001  RN II at Baptist Medical Center-Critical Care Department-Telemetry Unit 
   *Skills initiation and documentation R/T Cardiovascular/ 
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    Medical-Surgical Nursing: 
    -Admission profiles-Risk factor Management 
    -Identification/documentation of patient teaching, 
     learning, and psychosocial needs 
    -Development of measurable/realistic patient  
     outcomes 
    -Timely initiation of physician orders 
    -Clinical organization/crisis management 
    -Prioritization in delegation to health team members 
    -Safety in medication administration and related 
     cardiovascular nursing procedures 
 
1998-1999  RN II at Arkansas Heart Hospital 
 
1995-1996  Charge Nurse at Chenal Rehabilitation/Healthcare Center 
   *Long-term Care/Rehabilitation Nursing 
    -Restorative Feeding -Reality Orientation 
    -Ambulation Techniques -Alignment/Positioning 
    -Bowel/Bladder Training -Care plan Evaluation 
    -Isolation/Sterile Technique  
    -Infusaport/PCA/Central Venous therapy 
 
1994-1995  Charge Nurse at Hill Haven Healthcare Center on the skilled 
   care unit 
    -Supervision of CNA's  
    -Patient/family education; specifically, the trajectory 
     of acute/chronic illness in R/T the family unit in a  
     long-term care environment 
    -Consistent collaboration with various physicians 
     throughout the implementation of protocols/ 
     standing orders 
-Long-term management/administration of intravenous 
     anticoagulant therapy via CVL 
    -Conducted individual/group in-services on diabetic 
     skin/feet/nail care, updraft administration, enteral 
     feeding techniques, and stress management 
 
1995-2001   Primary RN for an Internal Medicine Physician 
   *Attending to Acute/Long-term/Rehabilitation 









2012-2013  Golden Key International Honor Society 
 
2012-2013  American Association of Diabetes Educators 
 
2010-2013  American Academy of Nurse Practitioners 
 
2009-2011  American College of Nurse Practitioners 
 
2002-2011  Little Rock Black Nurses Association 
 
2001-2005 Arkansas Medical & Dental Pharmaceutical Association 
 
2000- 2005  Sigma Theta Tau International Nursing Honor Society 
 
1999-2001  Dean's List at UAMS 
 
2000   Certified Sexual Assault Nurse Examiner 
 
2000   Cancer Chemotherapy Certification 
 
1998-2011  Advanced Cardiac Life Support Certification 
 
1993-2000  *Member of Sigma Theta Tau International Nursing 
    Honor Society 
   * Research Colloquium participant 
   *Attended Arkansas State Nurses Convention 
   *Member of Gamma Beta Phi Honor Society 
   *Member of Who's Who Among Students in American 
    Colleges and Universities 
   *AMDPA 
   *Attended Advanced Critical Care Conference 
   *Attended Cardiology/Critical-care Conference in 
    San Diego, CA 
 
1990-1994  Dean's List at University of Central Arkansas 
 






ACTIVITIES  *Member of Delta Sigma Theta Sorority, Inc. 
   *Volunteer for American Red Cross Association 
   *Volunteer for UAMS/VA Universal Wellness Project 
*Member of the Health Ministry at Second Baptist Church, LR, AR 
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*Volunteer consultant for Little Rock Healthcare and Rehabilitation 
Center 
-Providing in-services for Director of Nursing and entire nursing 
staff 
   *Preceptor for ACNP students from UAMS 
   *Preceptor for BSN students from UCA 
*Volunteer for numerous community wellness screenings and health fairs 
*Volunteer speaker for numerous church speaking engagements with 
focus on women’s’ health and wellness 
 
REFERENCES Available upon request 
     
 
 
